Announcements
- IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
- IGM Biosciences Announces Refocusing of Sanofi Collaboration
- IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
- IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
- IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
- IGM Biosciences Announces Third Quarter 2023 Financial Results
- IGM Biosciences to Present at Two Upcoming Investor Conferences
More ▼
Key statistics
On Friday, IGM Biosciences Inc (1K0:FRA) closed at 9.20, 150.00% above the 52 week low of 3.68 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.20 |
---|---|
High | 9.20 |
Low | 9.20 |
Bid | 8.75 |
Offer | 8.85 |
Previous close | 9.80 |
Average volume | 100.00 |
---|---|
Shares outstanding | 59.02m |
Free float | 22.06m |
P/E (TTM) | -- |
Market cap | 592.89m USD |
EPS (TTM) | -4.31 USD |
Data delayed at least 15 minutes, as of May 24 2024 14:45 BST.
More ▼